Collaborative AI Models for Drug Discovery
Basecamp Research Unveils Trillion Gene Atlas for AI
New genomic catalog of 100 million species aims to accelerate AI-driven therapeutic design.

A digital display showing complex 3D DNA models and interconnected neural network nodes, representing the intersection of genomics and artificial intelligence.
Photo: Avantgarde News
Basecamp Research announced the launch of the Trillion Gene Atlas to scale AI-designed therapeutics [1][2]. This initiative aims to catalog genomic data from more than 100 million species across the globe [1][3]. The massive dataset provides a foundation for training advanced AI models to identify new drug targets [2]. Basecamp Research is collaborating with technology leaders Anthropic and NVIDIA on the project [2][3]. These partnerships focus on training large-scale models for programmable biological design [1]. The goal is to create more precise treatments by leveraging a wider range of genetic diversity [3]. The atlas seeks to overcome limitations in current genomic databases by including diverse environmental samples [1][3]. This expansion could significantly improve the speed of drug discovery processes [2]. Details regarding specific therapeutic candidates were not confirmed in the available sources.
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
biospace.com
https://www.biospace.com/press-releases/basecamp-research-launches-trillion-gene-atlas-to-scale-ai-designed-therapeutics
- 2.↗
prnewswire.com
https://www.prnewswire.com/news-releases/basecamp-research-launches-trillion-gene-atlas-to-scale-ai-designed-therapeutics-302716632.html
- 3.↗
pharmaphorum.com
https://pharmaphorum.com/news/basecamp-lifts-veil-trillion-gene-atlas-genomics-push
Related stories
View allTopics
About the author
Avantgarde News Desk covers collaborative ai models for drug discovery and editorial analysis for Avantgarde News.


